Treatment of brodifacoum overdose with prothrombin complex concentrate.

Am J Health Syst Pharm

Yuchen Wang, Pharm.D., is Postgraduate Year 1 (PGY1) Pharmacy Resident, Department of Pharmacy, Monmouth Medical Center, Long Branch, NJ. Viktoriya Kotik, Pharm.D., is PGY1 Pharmacy Resident, Department of Pharmacy, Monmouth Medical Center, Southern Campus, Lakewood, NJ. Germin Fahim, Pharm.D., BCPS, is Clinical Assistant Professor, Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, State University of New Jersey, Piscataway, and Internal Medicine Pharmacist, Department of Pharmacy, Monmouth Medical Center, Long Branch. Sayee Alagusundaramoorthy, M.D., is PGY1 Medical Resident, Department of Internal Medicine; Sherif Ali eltawansy, M.D., is Postgraduate Year 2 Medical Resident, Department of Internal Medicine; and Scott Mathis, Pharm.D., is Director of Pharmacy, Department of Pharmacy, Monmouth Medical Center, Long Branch. Julie Saleh, Pharm.D., BCPS, is Clinical Associate Professor, Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, and Critical Care Pharmacist, Department of Pharmacy, Monmouth Medical Center, Long Branch.

Published: January 2016

Purpose: A case of brodifacoum overdose and its treatment with prothrombin complex concentrate (PCC) are reported.

Summary: A 44-year-old Caucasian woman weighing 62 kg arrived at the emergency department with a chief complaint of lower left leg pain for two days. A computed tomography (CT) scan of the abdomen revealed perihepatic fluid collection (likely a hematoma), a small-bowel intramural hematoma, and blood in the paracolic gutter. A CT scan of the patient's left foot showed soft tissue swelling without evidence of fracture or dislocation. The patient was diagnosed with left extremity compartment syndrome secondary to hematoma and trauma. The patient had a history of depression and anxiety and eventually admitted to ingesting large doses of brodifacoum the week prior with suicidal intentions. The patient was treated with phytonadione 20 mg i.v., 1 unit of fresh frozen plasma (FFP), and 1 unit of packed red blood cells. Laboratory test values measured in the intensive care unit revealed an International Normalized Ratio (INR) of 15, a prothrombin time of >120 seconds, and a partial prothromboplastin time of >180 seconds. After consulting with a local poison center, phytonadione 50 mg i.v., PCC 3100 units, and 4 units of FFP were immediately administered to reverse the patient's coagulopathy. The dose of oral phytonadione was lowered based on INR stability. Once the coagulopathy was stabilized, the patient was transferred to an inpatient psychiatric facility on phytonadione 10 mg daily orally to maintain a stable INR.

Conclusion: A 44-year-old woman who intentionally ingested brodifacoum was successfully treated with phytonadione, PCC, and FFP.

Download full-text PDF

Source
http://dx.doi.org/10.2146/ajhp150233DOI Listing

Publication Analysis

Top Keywords

brodifacoum overdose
8
prothrombin complex
8
complex concentrate
8
treated phytonadione
8
phytonadione pcc
8
phytonadione
5
treatment brodifacoum
4
overdose prothrombin
4
concentrate purpose
4
purpose case
4

Similar Publications

Effects of anticoagulant rodenticide poisoning on spatial behavior of farm dwelling Norway rats.

Sci Total Environ

September 2021

Julius Kühn Institute (JKI), Federal Research Centre for Cultivated Plants, Institute for Plant Protection in Horticulture and Forests, Vertebrate Research, Toppheideweg 88, 48161 Münster, Germany.

Commensal rodent species cause damage to crops and stored products, they transmit pathogens to people, livestock and pets and threaten native flora and fauna. To minimize such adverse effects, commensal rodents are predominantly managed with anticoagulant rodenticides (AR) that can be transferred along the food chain. We tested the effect of the uptake of the AR brodifacoum (BR) by Norway rats (Rattus norvegicus) on spatial behavior because this helps to assess the availability of dead rats and residual BR to predators and scavengers.

View Article and Find Full Text PDF

Background: Synthetic cannabinoids are a commonly used class of recreational drugs that can have significant adverse effects. There have been sporadic reports of co-consumption of illicit drugs with rodenticides such as warfarin and brodifacoum (BFC) over the past 20 years but recently, hundreds of people have been reported to have been poisoned with a mixture of synthetic cannabinoids and BFC. We have sought to establish whether BFC directly affects cannabinoid receptors, or their activation by the synthetic cannabinoid CP55940 or the phytocannabinoid Δ-tetrahydrocannabinol (Δ-THC).

View Article and Find Full Text PDF

Hemorrhagic Soft Tissue Upper Airway Obstruction From Brodifacoum-Contaminated Synthetic Cannabinoid.

J Emerg Med

July 2019

Department of Emergency Medicine, Cleveland Clinic Akron General, Akron, Ohio; Associate Professor, Northeastern Ohio Medical University, Rootstown, Ohio.

Background: More than 60 types of cannabinoids are found in nature; the remaining are chemically synthesized analogs of natural cannabinoids. Synthetic cannabinoids were first reported in the United States in 2008. These compounds are usually smoked by users and are sold under various names.

View Article and Find Full Text PDF

Pesticide-Poisoned Patients: Can They Be Used as Potential Organ Donors?

J Med Toxicol

December 2018

General Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Introduction: The gap between the number of patients on transplant waiting lists and patients receiving transplants is growing. Use of organs from donors who have died following pesticide exposure remains controversial. This study reviews the literature related to transplantation from this group.

View Article and Find Full Text PDF

Superwarfarins were developed following the emergence of warfarin resistance in rodents. Compared to warfarin, superwarfarins have much longer half-lives and stronger affinity to vitamin K epoxide reductase and therefore can cause death in warfarin-resistant rodents. By the mid-1970s, the superwarfarins brodifacoum and difenacoum were the most widely used rodenticides throughout the world.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!